Cargando…
Clinical Utility And Diagnostic Accuracy of Faecal Calprotectin For IBD At First Presentation To Gastroenterology Services In Adults Aged 16–50 Years
BACKGROUND: Distinguishing inflammatory bowel disease (IBD) from functional gastrointestinal (GI) disease remains an important issue for gastroenterologists and primary care physicians, and may be difficult on the basis of symptoms alone. Faecal calprotectin (FC) is a surrogate marker for intestinal...
Autores principales: | Kennedy, Nicholas A., Clark, Annalie, Walkden, Andrew, Chang, Jeff C.W., Fascí-Spurio, Federica, Muscat, Martina, Gordon, Brydon W., Kingstone, Kathleen, Satsangi, Jack, Arnott, Ian D.R., Lees, Charlie W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795527/ https://www.ncbi.nlm.nih.gov/pubmed/25135754 http://dx.doi.org/10.1016/j.crohns.2014.07.005 |
Ejemplares similares
-
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015) -
Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
por: Kennedy, Nicholas A., et al.
Publicado: (2019) -
Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
por: Fu, Yu, et al.
Publicado: (2017) -
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns
por: Festa, Stefano, et al.
Publicado: (2020) -
Calprotectin instability may lead to undertreatment in children with IBD
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2020)